CancerCare

Last year, @CancerCare provided 150,508 services to people diagnosed with cancer, caregivers and bereaved individuals. Our emotional, practical and financial support programs continued to offer help and hope to anyone affected by cancer. Learn more at cancercare.org.

#ClinicalTrials can save lives from cancer. But not everyone can access them. Congress has an opportunity to change this with a new bill. (1/2)

Cancer Support Community is joined by other cancer advocacy organizations in strongly opposing provisions in the CMS interim final rule. See our joint statement here: cancersupportcommunity.org/sites/default/…

The @US_FDA has approved capivasterib plus abiraterone and prednisone for patients with PTEN- deficient metastatic hormone-sensitive prostate cancer. #pcsm | @FDAOncology cancernetwork.com/view/capivaser…

The FDA has approved belzutifan in combination with pembrolizumab for the adjuvant treatment of adult patients with clear cell renal cell carcinoma at high risk of recurrence: hubs.li/Q04lfvkl0 #RenalCellCarcinoma #FDAApproval #Belzutifan #Pembrolizumab #Welireg #Keytruda

Finding platinum-resistant #ovariancancer and #endometrialcancer clinical trials can feel overwhelming. Our trial finder supports people with cancer as they explore potential study options, such as the BEHOLD-1 study. Learn more: buff.ly/omN9Qqa #CancerCare #ClinicalTrial

BRONZE | CancerCare @CancerCare | myTRIAList (Web-based Digital Health: Website) #DHAS2026

During this edition of #AntibodyHour 🕙, hear from Vilmarie Rodriguez, VP of Patient Assistance & Community Engagement at @CancerCare who shares about Cancer Care’s work in developing programs for patients through counseling, support groups and patient advocacy. She shares how she has found purpose in helping others. Her mission inspires us at Genmab as we move with the ambition to transform the lives of people living with cancer through innovative antibody medicines. #PatientFirst

Health insurance barriers are disrupting the lives of people with cancer. CancerCare has been listening – and now it’s time to act. Join us on June 17 for the Micro Insights, Macro Impact webinar. Register here: us06web.zoom.us/webinar/regist… #HealthcarePolicy #PatientAdvocacy

Neeta Somaiah, MD, gave her perspective on GIST clinical trials in myTRIAList’s INSIGHT study overview video. Keep up to date on the latest trial-overview videos in @CancerCare's myTRIAList Trial Finder here: buff.ly/2aa3NHI #GISTawareness #cancerresearch #oncologist #MD

FDA approves durvalumab in combination with Bacillus Calmette-Guerin for high-risk non-muscle invasive bladder cancer fda.gov/drugs/resource…

FDA approves pivekimab sunirine-pvzy for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare hematologic malignancy fda.gov/drugs/resource…

#FDA approves a treatment for unresectable or metastatic triple-negative breast cancer. fda.gov/drugs/resource…

FDA Approves First Early-Stage Breast Cancer Indications for Trastuzumab Deruxtecan oncologynewscentral.com/drugs/info/fda…

#FDA approves a treatment for acute myeloid leukemia. fda.gov/drugs/resource…

#FDA grants accelerated approval to a treatment for relapsed or refractory mantle cell lymphoma. fda.gov/drugs/resource…

The FDA approves zenocutuzumab-zbco for advanced, unresectable or metastatic cholangiocarcinoma fda.gov/drugs/resource…

On 5/20🗓️, join the Lank Center's Dr. Stephanie Berg @bergsa83 and colleagues for a teleconference on #bladdercancer titled "Bladder Cancer: Treatment Updates" Part I of a two-part series on Living with Bladder Cancer, organized by @CancerCare & @BladderCancerUS

FDA Approves Vepdegestrant for ESR1-Mutated Advanced Breast Cancer: oncologynewscentral.com/drugs/info/fda…

📣Today is AML World Awareness Day! Today, we unite as a global community to raise awareness of acute myeloid leukemia (AML) and show support for every patient, caregiver, and family affected by this cancer. Join our campaign now: loom.ly/VvFaAMQ #KnowAML #AMLAwarenessDay

It took years before Becky felt like she was truly heard by a doctor. Her story and those of other #HeadAndNeckCancer (HNC) and #thyroidcancer (TC) survivors show the power of self-advocacy as they share their diagnosis journeys. See more on YouTube: bit.ly/4l2M2LT #ad